MacroGenics Provides Update on Corporate Progress and 2020 Financial Results

NEXT STORY
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
PREV STORY
Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CareDx Announces New Clinical Data on AlloMap Score Variability and Service to Support Assessment of Long-Term Transplant Recipient Risk

BRISBANE, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics ...

author_avatar
NASDAQ Market News

Shire plc : Director/PDMR Shareholding

Director/PDMR Shareholding March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of ...

author_avatar
NASDAQ Market News

eFFECTOR Initiates Dosing of eFT508 in Phase 2 Expansion of Clinical Trial in Aggressive Form of Non-Hodgkin’s Lymphoma

SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in ...

author_avatar
NASDAQ Market News